4//SEC Filing
Prentiss Christopher B 4
Accession 0001209191-20-020266
CIK 0001328143other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:21 PM ET
Size
5.0 KB
Accession
0001209191-20-020266
Insider Transaction Report
Form 4
Prentiss Christopher B
Chief Accounting Officer
Transactions
- Award
Common Stock
2020-03-17+10,000→ 80,940 total
Footnotes (1)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest on January 31, 2021.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001717583
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:21 PM ET
- Size
- 5.0 KB